Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Prospective Phase II of Daratumumab in Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Murielle Roussel, MD, Anne-Marie Stoppa, MD, Aurore Perrot, MD, Lionel Karlin, MD, Bertrand Arnulf, MD PhD, Margaret Macro, MD, Antoine Huart, MD, Laurent Frenzel, MD PhD, Pierre Morel, MD, Eileen Boyle, MD, Veronique Dorvaux, MD, Giampaolo Merlini, MD, Giovanni Palladini, MDPhD, David Lavergne, PhD, Frank Bridoux, MD PhD, Arnaud Jaccard

Blood (2017) 130 (Supplement 1): 508.

https://doi.org/10.1182/blood.V130.Suppl_1.508.508

Published: 2017

Journal Articles

Continued Improvement and Normalization of Myocardial T2* In Patients with β-thalassemia Major Treated with Deferasirox (Exjade®) for up to 3 Years

Dudley Pennell, MD, John B. Porter, MD, Maria Domenica Cappellini, MD, Lee Lee Chan, MD, Amal El-Beshlawy, MD, Yesim Aydinok, MD, Hishamshah Ibrahim, MD, Chi-Kong Li, MD, Vip Viprakasit, MD, DPhil, Mohsen Saleh Elalfy, MD, Antonis Kattamis, MD, Gillian Smith, MSc, Dany Habr, MD, Gabor Domokos, PhD, Bernard Roubert, PhD, Ali Taher, MD

Blood (2010) 116 (21): 4276.

https://doi.org/10.1182/blood.V116.21.4276.4276

Published: 2010

Journal Articles

R-CHOP Modified with Pegilated Lyposomal Adriamycin in Elderly Diffuse Large B-Cell Non Hodgkin’s Lymphoma (DLBC-NHL) Therapy: An Attempt To Reduce Toxicity in Patients with Comorbidity.

Giulio Giordano, MD, Matteo Dell’Olio, MD, Silvia Piano, MD, Giuliana Farina, MD, Antonio La Sala, MD, Daniele Colaprete, MD, Nicola Cascavilla, MD, Sergio Storti, MD

Blood (2007) 110 (11): 4469.

https://doi.org/10.1182/blood.V110.11.4469.4469

Published: 2007

Journal Articles

Should High-Risk Patients with Chronic Atrial Fibrillation and Those with Coronary Artery Disease Receive Combined Aspirin-Oral Anticoagulant Therapy or Oral Anticoagulant Therapy Alone? A Systematic Review and Meta-Analysis.

Francesco Dentali, MD, Wendy Lim, FRCP, James D. Douketis

Blood (2005) 106 (11): 904.

https://doi.org/10.1182/blood.V106.11.904.904

Published: 2005

Journal Articles

Platelet Activation Promotes Formation of Platelet-Leukocyte Conjugates (PLC) in Non-Valvular Atrial Fibrillation (AF).

Aurelio Castrellon, MD, Julio A. Chirinos, MD, Juan P. Zambrano, MD, Wenche Jy, PhD, Lawrence L. Horstmann, MS, Eugene R. Ahn, MD, Joaquin J. Jimenez, MD, Howard Willens, MD, Agustin Castellanos, MD, Robert J. Myerburg, MD, Yeon S. Ahn, MD

Blood (2004) 104 (11): 3513.

https://doi.org/10.1182/blood.V104.11.3513.3513

Published: 2004

NARROW

A Prospective Phase II of Daratumumab in Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Continued Improvement and Normalization of Myocardial T2* In Patients with β-thalassemia Major Treated with Deferasirox (Exjade®) for up to 3 Years

R-CHOP Modified with Pegilated Lyposomal Adriamycin in Elderly Diffuse Large B-Cell Non Hodgkin’s Lymphoma (DLBC-NHL) Therapy: An Attempt To Reduce Toxicity in Patients with Comorbidity.

Should High-Risk Patients with Chronic Atrial Fibrillation and Those with Coronary Artery Disease Receive Combined Aspirin-Oral Anticoagulant Therapy or Oral Anticoagulant Therapy Alone? A Systematic Review and Meta-Analysis.

Platelet Activation Promotes Formation of Platelet-Leukocyte Conjugates (PLC) in Non-Valvular Atrial Fibrillation (AF).

Email alerts

ASH Publications

American Society of Hematology

A Prospective Phase II of Daratumumab in Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Continued Improvement and Normalization of Myocardial T2* In Patients with β-thalassemia Major Treated with Deferasirox (Exjade®) for up to 3 Years

R-CHOP Modified with Pegilated Lyposomal Adriamycin in Elderly Diffuse Large B-Cell Non Hodgkin’s Lymphoma (DLBC-NHL) Therapy: An Attempt To Reduce Toxicity in Patients with Comorbidity.

Should High-Risk Patients with Chronic Atrial Fibrillation and Those with Coronary Artery Disease Receive Combined Aspirin-Oral Anticoagulant Therapy or Oral Anticoagulant Therapy Alone? A Systematic Review and Meta-Analysis.

Platelet Activation Promotes Formation of Platelet-Leukocyte Conjugates (PLC) in Non-Valvular Atrial Fibrillation (AF).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only